Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00827762 · ClinicalTrials.gov registry record

Behavioral Effects of Kuvan in Children With Mild Phenylketonuria

A clinical trial, sponsored by Washington University School of Medicine.

Terminated
Registry status
2
Enrollment target

NCT00827762: Clinical Trial study, sponsored by Washington University School of Medicine.

NCT00827762 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00827762 was terminated before completion, sponsored by Washington University School of Medicine.

TERMINATED
Registry status
2 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether improvements in behavior occur in children with phenylketonuria (PKU) who are taking Kuvan.

Interventions

  • DRUG Kuvan

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2009-01
Est. Completion 2010-01

Why NCT00827762 stopped before completion

NCT00827762 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Kuvan is the first listed.

NCT00827762 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00827762 about?

NCT00827762 is a clinical study titled "Behavioral Effects of Kuvan in Children With Mild Phenylketonuria". The purpose of this study is to determine whether improvements in behavior occur in children with phenylketonuria (PKU) who are taking Kuvan.

What is the current status of trial NCT00827762?

This trial is currently terminated. The enrollment target is 2 participants. The study started on 2009-01. Estimated completion is 2010-01.

What interventions are being tested in trial NCT00827762?

The interventions under investigation include: Kuvan (DRUG).

Who is sponsoring clinical trial NCT00827762?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00827762, the US trial registry maintained by the National Library of Medicine. NCT00827762 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.